Hematopoietic Stem Cell Transplant
Showing 9976 - 10000 of >10,000
Lung Cancer Trial in New York (mAb hu3S193)
Completed
- Lung Cancer
- monoclonal antibody hu3S193
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Feb 7, 2022
Brain Metabolic Network of PET in Advanced Non-Small Cell Lung
Completed
- Advanced Non-small-cell Lung Cancer
- None of any intervention
-
Zhuhai, Guangdong, ChinaPET/CT
May 18, 2022
Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Ipilimumab)
Terminated
- Renal Cell Carcinoma
- Nivolumab
- Ipilimumab
-
Saint Louis, Missouri
- +11 more
Dec 15, 2022
Advanced NSCLC Trial in Beijing, Harbin, Tianjin (utidelone injection)
Completed
- Advanced Non-small Cell Lung Cancer
- utidelone injection
-
Beijing, Beijing, China
- +3 more
Jan 8, 2023
Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)
Active, not recruiting
- Prostate Cancer
- Abiraterone Acetate
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 6, 2022
Acute Myeloid Leukemia, Blasts 20 Percent or More of Bone Marrow Nucleated Cells, High Risk Myelodysplastic Syndrome Trial in
Recruiting
- Acute Myeloid Leukemia
- +7 more
- Cladribine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 7, 2022
NSCLC, Lung Cancer, NSCLC Trial in United States (G1T38, Osimertinib)
Completed
- Carcinoma, Non-Small-Cell Lung
- +2 more
-
Beverly Hills, California
- +7 more
Sep 20, 2022
COVID-19 Vaccination in Multiple Sclerosis Patients Treated With
Completed
- Multiple Sclerosis
- +7 more
- Elecsys semi-quantitative Anti-SARS-CoV-2 antibody test
- T-Detect COVID T-cell blood test
-
Wellesley, MassachusettsDragonfly Research, LLC
Jul 26, 2021
MuSK Myasthenia Gravis Trial (MuSK-CAART)
Not yet recruiting
- MuSK Myasthenia Gravis
- MuSK-CAART
- (no location specified)
Jul 5, 2022
EBV Associated Extranodal NK/T-cell Lymphoma, EBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma Trial in Korea,
Recruiting
- EBV Associated Extranodal NK/T-cell Lymphoma
- EBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma
- EBViNT Cell
-
Seoul, Gangnam-gu, Korea, Republic of
- +7 more
Jul 7, 2022
Pancreatic Tumor Trial in Shanghai (Personalized neoantigen vaccine)
Recruiting
- Pancreatic Tumor
- Personalized neoantigen vaccine
-
Shanghai, Shanghai, ChinaChanghai Hospital
Mar 8, 2022
Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Atlanta (Lurbinectedin, Palliative Radiation
Not yet recruiting
- Extensive Stage Lung Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Lurbinectedin
- Palliative Radiation Therapy
-
Atlanta, Georgia
- +2 more
Apr 12, 2022
Alcohol Drinking Trial in New Haven (Propranolol, Placebo)
Recruiting
- Alcohol Drinking
- Propranolol
- Placebo
-
New Haven, ConnecticutYale University School of Medicine
Jan 12, 2023
NSCLC Trial in Ostrava (primary tumour radiotherapy, stereotactic body radiotherapy, maintenance radiotherapy)
Recruiting
- Non-small Cell Lung Cancer
- primary tumour radiotherapy
- +2 more
-
Ostrava, Moravian-Silesian Region, CzechiaUniversity Hospital Ostrava
Dec 6, 2022
Horton Disease Trial in France (chewing gum)
Active, not recruiting
- Horton Disease
- chewing gum
-
Avignon, France
- +5 more
Nov 16, 2021
Resectable Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Houston
Terminated
- Resectable Lung Non-Small Cell Carcinoma
- +10 more
- Bintrafusp Alfa
- Therapeutic Conventional Surgery
-
Houston, TexasM D Anderson Cancer Center
Jul 27, 2022
Urinary Stress Incontinence Trial in Zürich (Muscle Precursor Cells (MPCs), ATMP)
Completed
- Urinary Stress Incontinence
- Muscle Precursor Cells (MPCs), ATMP
-
Zürich, SwitzerlandUniversity Hospital Zurich
Nov 2, 2021
Head and Neck Tumors Trial (TransCon TLR7/8 Agonist, Pembrolizumab, TransCon IL-2 ß/?)
Not yet recruiting
- Head and Neck Neoplasms
- TransCon TLR7/8 Agonist
- +2 more
- (no location specified)
Aug 4, 2023
Head Neck Cancer Trial in Tyler (Buparlisib & Paclitaxel)
Recruiting
- Head and Neck Cancer
- Buparlisib & Paclitaxel
-
Tyler, TexasHope Cancer Center, UT Health East Texas
Aug 11, 2022
Anemia; Sickle-Cell, With Crisis, Acute Pain Trial in Durham (Ketamine, Pain management)
Withdrawn
- Anemia; Sickle-Cell, With Crisis
- Acute Pain
- Ketamine
- Pain management
-
Durham, North CarolinaDuke Hospital
Dec 29, 2021
Type 2 Diabetes, Mesenchymal Stem Cells Trial in Beijing (Umbilical cord mesenchymal stem cells, Controlled suspension liquid)
Completed
- Type 2 Diabetes
- Mesenchymal Stem Cells
- Umbilical cord mesenchymal stem cells
- Controlled suspension liquid
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Feb 1, 2021
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC (American Joint Committee on Cancer) v8, Clinical
Active, not recruiting
- Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC (American Joint Committee on Cancer) v8
- +8 more
- Durvalumab
- +6 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Dec 7, 2021
Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8, Stage IV Cutaneous Squamous Cell Carcinoma of the Head
Completed
- Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
- Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
- Gabapentin
- +6 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 8, 2021